SHE · Healthcare
Drug Manufacturers - Specialty & Generic
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd (301130) is listed on SHE in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-28, reported market cap is $2.37B, P/E ratio is 59.69, net margin is 15.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd (301130) has a reported market cap of $2.37B (data as of 2026-03-28).
The price-to-earnings (P/E) ratio for Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd (301130) is 59.69 (data as of 2026-03-28).
Dividend yield is not available in the current snapshot for Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd (301130). Check the MyAverix Finance app for the latest dividend data.
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd (301130) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
301130 is listed on SHE.
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd (301130) reports a net margin of 15.6% (data as of 2026-03-28).
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.